EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
The Motley Fool: What's 'the Dow'? - UPSTATE BUSINESS JOURNAL
SG Americas Securities LLC Has $75.53 Million Stake in Bristol Myers Squibb Company $BMY
SG Americas Securities LLC Buys 1,177,732 Shares of Bristol Myers Squibb Company $BMY - Stock Observer
Is Bristol Myers Squibb (BMY) Quietly Recasting Its Post-Patent Story With Opdivo And KarXT Moves?
Clinical outcomes with perioperative nivolumab by nodal status in patients with stage III resectable NSCLC: phase 3 CheckMate 77T exploratory analysis
Assessing Bristol Myers Squibb (BMY) Valuation As Shares Gain And Profitability Narrative Evolves
Is Bristol Myers Squibb (BMY) Pricing Reflect Recent Opdivo And Eliquis Patent Cliff Risks
How Bristol Myers Squibb Transformed Working Capital to Fund Its Future - SPONSOR CONTENT FROM EY-PARTHENON
UBS Group Upgrades Bristol Myers Squibb (NYSE:BMY) to Buy
Bristol Myers Squibb (NYSE:BMY) Rating Increased to Buy at UBS Group - Markets Daily
Integras Partners LLC Buys 22,141 Shares of Bristol Myers Squibb Company $BMY
Bristol Myers Squibb Company $BMY Shares Sold by Commonwealth Equity Services LLC
Assessing Bristol Myers Squibb (BMY) Valuation After New Eliquis Pact Trial Update And Opdivo Approval
Alnuctamab, a bivalent B-cell maturation antigen-targeting T cell engager for patients with relapsed or refractory multiple myeloma: results from a phase 1, first-in-human study
CD19 CAR-T cells for treatment-refractory autoimmune diseases: the phase 1/2 CASTLE basket trial
Gladstone Institutional Advisory LLC Has $4.50 Million Stock Holdings in Bristol Myers Squibb Company $BMY - Markets Daily
Bristol Myers Squibb Company $BMY Position Decreased by D.A. Davidson & CO.
Robeco Institutional Asset Management B.V. Buys 409,231 Shares of Bristol Myers Squibb Company $BMY - Stock Observer
Is Bristol Myers Squibb (BMY) Pricing Reflect Pipeline Progress And DCF Valuation Gap
Railway Pension Investments Ltd Purchases 40,300 Shares of Bristol Myers Squibb Company $BMY
Bristol Myers Squibb Company $BMY Shares Acquired by CWA Asset Management Group LLC
The Motley Fool: Dividends and a chance for growth
Binimetinib and encorafenib for the treatment of advanced solid tumors with non-V600E BRAF mutations: results from the Phase II BEAVER trial
Bristol Myers Squibb to Present at J.P. Morgan's 44th Annual Healthcare Conference
Allspring Global Investments Holdings LLC Acquires 434,745 Shares of Bristol Myers Squibb Company $BMY
Tumor ecosystem and microbiome features associated with efficacy and resistance to avelumab plus chemoradiotherapy in head and neck cancer
Bristol Myers Squibb Sees Unusually Large Options Volume (NYSE:BMY) - Markets Daily
Drugmakers hike US prices on 350 medicines despite pressure from Trump
Bristol Myers Squibb Sees Unusually High Options Volume (NYSE:BMY) - Stock Observer
VIRGINIA RETIREMENT SYSTEMS ET Al Grows Stock Holdings in Bristol Myers Squibb Company $BMY
3Chopt Investment Partners LLC Sells 36,326 Shares of Bristol Myers Squibb Company $BMY
VIRGINIA RETIREMENT SYSTEMS ET Al Acquires 679,000 Shares of Bristol Myers Squibb Company $BMY - Daily Political
Goldman Sachs Raises Bristol-Myers (BMY) Target, Keeps Neutral Rating
Bristol Myers Squibb Company $BMY Shares Purchased by Fort Washington Investment Advisors Inc. OH
Bristol Myers Squibb Company $BMY Shares Sold by Range Financial Group LLC
Ethic Inc. Raises Stock Holdings in Bristol Myers Squibb Company $BMY
What Does Wall Street Think About Bristol-Myers Squibb Company (BMY)?
Biotech Stocks Facing FDA Decision In January 2026
Bristol Myers Squibb Company $BMY Stock Holdings Reduced by Valley National Advisers Inc.
Spotlight | - The Times of India
An ultrasmall core-shell silica nanoparticle improves antitumour immunity and survival by remodelling suppressive melanoma microenvironments
Bristol Myers Squibb Company $BMY Shares Bought by Cwm LLC
Efficacy and safety of isatuximab subcutaneous plus carfilzomib and dexamethasone in patients with relapsed/refractory multiple myeloma: results of the Phase 2 study IZALCO
Donald L. Hagan LLC Purchases Shares of 20,550 Bristol Myers Squibb Company $BMY
Bristol Myers Squibb Company $BMY Shares Sold by Pacer Advisors Inc. - Stock Observer
Trust Co. of Toledo NA OH Increases Stock Position in Bristol Myers Squibb Company $BMY - Daily Political
Medical Stocks Worth Watching - December 25th - Daily Political
Bristol Myers Squibb (BMY): Reassessing Valuation After Breyanzi's Landmark FDA Approval in Marginal Zone Lymphoma
Vontobel Holding Ltd. Sells 46,675 Shares of Bristol Myers Squibb Company $BMY - Markets Daily
Vontobel Holding Ltd. Lowers Stock Position in Bristol Myers Squibb Company $BMY - Stock Observer
Bristol Myers Squibb Company (NYSE:BMY) Given Consensus Recommendation of "Hold" by Brokerages
Is Bristol Myers Squibb (BMY) Still Undervalued After Its Recent Share Price Rebound?
Bristol Myers Squibb Accelerates Drug Launches in India with AI Innovations, ETPharma
Bristol-Myers (BMY) Offers Eliquis Free to Medicaid Patients Under New Pricing Pact
Bristol Myers lines up many launches for India with 'AI' speed - The Economic Times
Four quiet Q4 winners and what the stocks must do to keep rolling in 2026
U.S. Capital Wealth Advisors LLC Sells 47,717 Shares of Bristol Myers Squibb Company $BMY
Coho Partners Ltd. Has $2.18 Million Stock Holdings in Bristol Myers Squibb Company $BMY
True North Advisors LLC Takes Position in Bristol Myers Squibb Company $BMY - Stock Observer
Trust Co. of Vermont Has $2.55 Million Stock Holdings in Bristol Myers Squibb Company $BMY - Stock Observer
Exchange Traded Concepts LLC Purchases 83,214 Shares of Bristol Myers Squibb Company $BMY
Bristol Myers Squibb Company $BMY Shares Sold by First Bank & Trust
Vagus nerve-mediated neuroimmune modulation for rheumatoid arthritis: a pivotal randomized controlled trial
FDA Approves Bristol-Myers Squibb's Breyanzi as First-Ever CAR T Therapy for Rare Marginal Zone Lymphoma
BofA Upgrades Bristol-Myers Squibb (BMY) Stock to Buy from Neutral
Bristol Myers Squibb Company $BMY Shares Sold by Wedge Capital Management L L P NC
Should Retirees Pull Their Money Out of the Stock Market in 2026?
Bristol Myers Squibb Company $BMY Shares Sold by Voya Investment Management LLC - Stock Observer
Great week for Bristol-Myers Squibb Company (NYSE:BMY) institutional investors after losing 0.8% over the previous year
Bristol Myers Squibb Company $BMY Shares Sold by Contravisory Investment Management Inc.
10 Best Stocks to Invest in for the Next 3 Years
HBM Holdings (SEHK:2142): Valuation Check After Bristol Myers Squibb Collaboration Validates Growth Prospects
Drug companies line up to make deals with Trump after initial hesitation
Trump unveils major drug price deals with 9 Pharma giants, launches TrumpRx.gov to cut medicine costs in US
Trump announces lower drug price deals with 9 pharmaceutical companies
TrumpRx latest news today: TrumpRx explained: How Trump's new drug price deals with 9 pharma companies could save patients money - The Economic Times
Eliquis® (apixaban), the Nation's #1 Prescribed Oral Blood T
10 Best Stocks to Buy for the Next 5 Years
Rep. Julie Johnson Sells Off Shares of Bristol Myers Squibb Company (NYSE:BMY) - Markets Daily
Trump to announce new deals with major drugmakers to lower US prescription drug prices
I'll Play, Says Jim Cramer About Bristol-Myers (BMY)
Zacks Research Has Pessimistic Outlook of BMY Q3 Earnings - Markets Daily
Montecito Bank & Trust Invests $567,000 in Bristol Myers Squibb Company $BMY
Several top drugmakers to lower US prices for some drugs-sources
Medicare enrollees to pay 50% less for some drugs in 2025, report says - Yahoo News Canada
Bristol Myers Squibb (NYSE:BMY) Stock Acquired Rep. Gilbert Ray Cisneros, Jr.
Czech National Bank Acquires 19,513 Shares of Bristol Myers Squibb Company $BMY
Corient Private Wealth LLC Sells 22,382 Shares of Bristol Myers Squibb Company $BMY
Bristol Myers Squibb and Accenture Unveil Mosaic: Mumbai's First AI-Powered Content Hub, ETPharma
Redefining gastroesophageal junction cancer care with perioperative immunotherapy, minimal residual disease monitoring and new targets
